Radiation therapy delivered soon after cisplatin administration is used for the treatment of advanced head and neck cancer. A radiation dose of 4800 cGy is given in standard fractions, followed by clinical evaluation and either surgical resection or an additional radiation dose of 2000 cGy. The histopathology of the surgical specimens from 21 patients undergoing resection in this protocol is compared with the corresponding clinical evaluation of tumor response. A significant number of both false negative and false positive clinical assessments are revealed by this comparison. In addition, it appears that local control of bulky head and neck cancer is approached by 4800 cGy combined soon after cisplatin. Discussion of the likely bases for this apparently favorable clinical interaction between cisplatin and radiation is presented.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0360-3016(85)90113-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gender-Affirming Voice Therapy Duration and Satisfaction: Experiences from a Single Institution.
J Voice
January 2025
UCSF Voice and Swallowing Center, Department of Otolaryngology - Head and Neck Surgery, University of California San Francisco, San Francisco, California. Electronic address:
Objective: Current literature involving gender-affirming voice therapy (GAVT) for transgender and nonbinary (TGNB) individuals is limited. This study describes treatment duration and satisfaction at a single institution.
Study Design: Retrospective cohort.
Repairing the Nasal Valve in Revision Surgery.
Otolaryngol Clin North Am
January 2025
Department of Otolaryngology-Head and Neck Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA; Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head & Neck Surgery, Penn State College of Medicine, Facial Nerve Clinic, Esteem Penn State Health Cosmetic Associates, 500 University Drive H-091, Hershey, PA. Electronic address:
Nasal airway obstruction is a frequent complaint in an otolaryngology clinic and is often multifactorial. Anatomic contributors may include a nasal septal deviation, inferior turbinate hypertrophy, and nasal valve compromise. Septoplasty and inferior turbinate reduction are one of the most common procedures performed by an otolaryngologist.
View Article and Find Full Text PDFA case report on surgical management of glomus tympanicum and literature review.
Int J Surg Case Rep
January 2025
Department of Otolaryngology-Head and Neck Surgery, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Introduction: Glomus tympanicum is a benign tumor classified under the group glomus tumors, and is also known as paragangliomas.
Case Presentation: A 52 years old woman presented with unilateral pulsatile tinnitus and hearing loss. She had a visible reddish mass behind the eardrum; Temporal bone CT scans suggested middle ear mass secondary to Glomus Tympanicum tumors.
FDG PET-CT missed tibial metastasis in head and neck cancer, case report and systematic review.
Int J Surg Case Rep
December 2024
Bibliothèque des Sciences de la Santé, Université libre de Bruxelles (ULB), Campus Erasme - CP 607, Route de Lennik, 808, 1070 Bruxelles, Belgium. Electronic address:
Introduction: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common type of cancer in the world. Metastases occur in up to 40 % of cases and bones are the second most frequent site. Metastases in extremities are uncommon with very few publications covering distal lower-limb bone metastasis.
View Article and Find Full Text PDFExploring PANoptosis in head and neck cancer: A novel approach to cancer therapy.
Ecotoxicol Environ Saf
January 2025
Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China. Electronic address:
PANoptosis is a newly discovered complex programmed cell death (PCD) form. In the field of cancer research, PANoptosis is involved in multiple cell death pathways that affect tumor cell survival, proliferation, and response to treatment, serving as an innovative strategy for cancer therapy. Endocrine-disrupting chemicals (EDCs) impact the endocrine system, including cancer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!